Detalhe da pesquisa
1.
Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel Diseases.
Dig Dis Sci
; 66(8): 2610-2618, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839905
2.
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.
Crohns Colitis 360
; 6(2): otae023, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38681979
3.
Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases.
J Clin Med
; 12(7)2023 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37048755
4.
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Crohns Colitis 360
; 5(4): otad053, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37859629
5.
Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center.
Turk J Gastroenterol
; 33(4): 320-328, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550540